This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DuPont Risks Dow Industrials Legacy as Transformation Looms

" We have been carefully weighing the strong cash generation of our Performance Chemicals businesses against their cyclicality and lower growth profile, as well as where the power of DuPont's integrated science can be differentiated," DuPont CEO Kullman said in a press release.

DuPont also reshuffled its management ranks on Tuesday, expanding the role of James C. Collins and Matthew L. Trerotola.

In second quarter earnings released on Tuesday, DuPont said its operating earnings fell to $1.28 a share from $1.50 at this time last year. While the company's bottom line slightly beat Wall Street estimates, quarterly revenue fell to $9.84 billion, missing consensus.

Operating profits at DuPont's performance chemicals business dropped 56% as a result of the falling price of titanium dioxide, otherwise known as TiO2.

"DuPont is now the third company to publicly explore strategic alternatives for its Ti02 business, with the other two yet to make meaningful progress," noted Andrews, the Morgan Stanley analyst.

Peltz of Trian Fund Management, meanwhile, may be interested in corporate breakups as a way to drive new growth and acquisitions.

At a CNBC conference earlier in July, Peltz said he would push for Pepsico (PEP - Get Report) to acquire Mondelez, the legacy Kraft business, in what would be among the largest corporate mergers in recent years.

DuPont shares were less than 1% to $57.51 in Tuesday afternoon trading.

Trian Fund Management didn't immediately respond to a call seeking comment.

-- Written by Antoine Gara in New York

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DD $74.83 4.60%
MDLZ $36.80 -0.05%
MON $117.70 -0.64%
PEP $94.50 -0.70%
AAPL $134.68 3.40%


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs